Glycan‐binding specificities of anti‐ <scp>ABO</scp> (H) antibodies and lectins
This glycan microarray data expands our understanding of the glycan specificities of commonly used ABO blood group binding reagents and indicates that caution should be used in interpretations of their binding.
Authors
- Ea Kristine Clarisse Tulin (ORCID: https://orcid.org/0000-0002-8889-5317)
- Melissa Y. Yeung (ORCID: https://orcid.org/0000-0002-1130-3192)
- Marie A. Hollenhorst (ORCID: https://orcid.org/0000-0002-2237-6645)
- Sean R. Stowell (ORCID: https://orcid.org/0000-0002-1130-9551)
- Richard D. Cummings (ORCID: https://orcid.org/0000-0002-8918-5034)
- William J. Lane (ORCID: https://orcid.org/0000-0002-1097-5229)
- K.M. Charon
- Prisca Hamm (ORCID: https://orcid.org/0000-0001-7164-0695)
- Jamie Heimburg‐Molinaro (ORCID: https://orcid.org/0000-0003-4987-3016)
- Akul Y. Mehta (ORCID: https://orcid.org/0000-0002-3450-3461)
Institutions
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
Publication Details
- Journal
- Transfusion
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1111/trf.70027
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Brigham and Women's Hospital
- Massachusetts Life Sciences Center
- Deutsche Forschungsgemeinschaft
- National Institutes of Health